Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys

Alvin V. Terry, Jerry J. Buccafusco, William J. Jackson

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


The basis for the memory enhancing action of nicotine was evaluated in five adult monkeys (Macaca fascicularis) well trained in the performance of a delayed matching-to-sample (DTMS) paradigm. Nicotine (1.25-20 μg/kg, IM) produced a dose-dependent improvement in performance of the task. The optimal dose of nicotine for each monkey also improved performance when the animals were tested 24 h later in the no-drug situation. In the same animals, low doses of scopolamine produced a dose-dependent decrement in DTMS performance. A subthreshold dose (defined by DMTS performance decrement) of scopolamine was administered 20 min prior to the optimal dose of nicotine. Scopolamine pretreatment completely blocked the enhanced performance observed earlier with nicotine. The results of this study are consistent with the hypothesis that the enhanced cognitive performance associated with nicotine is due to central acetylcholine release and subsequent muscarinic receptor stimulation.

Original languageEnglish (US)
Pages (from-to)925-929
Number of pages5
JournalPharmacology, Biochemistry and Behavior
Issue number4
StatePublished - Aug 1993


  • Alzheimer's disease
  • Learning and memory
  • Matching-to-sample Cholinergic
  • Monkey
  • Nicotine
  • Scopolamine

ASJC Scopus subject areas

  • Biochemistry
  • Toxicology
  • Pharmacology
  • Clinical Biochemistry
  • Biological Psychiatry
  • Behavioral Neuroscience


Dive into the research topics of 'Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys'. Together they form a unique fingerprint.

Cite this